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ABSTRACT Recent evidence indicates that inhibition of HIV-1 integrase (IN) binding
to the viral RNA genome by allosteric integrase inhibitors (ALLINIs) or through muta-
tions within IN yields aberrant particles in which the viral ribonucleoprotein com-
plexes (vRNPs) are eccentrically localized outside the capsid lattice. These particles
are noninfectious and are blocked at an early reverse transcription stage in target
cells. However, the basis of this reverse transcription defect is unknown. Here, we
show that the viral RNA genome and IN from ALLINI-treated virions are prematurely
degraded in target cells, whereas reverse transcriptase remains active and stably as-
sociated with the capsid lattice. The aberrantly shaped cores in ALLINI-treated parti-
cles can efﬁciently saturate and be degraded by a restricting TRIM5 protein, indicat-
ing that they are still composed of capsid proteins arranged in a hexagonal lattice.
Notably, the fates of viral core components follow a similar pattern in cells infected
with eccentric particles generated by mutations within IN that inhibit its binding to
the viral RNA genome. We propose that IN-RNA interactions allow packaging of both
the viral RNA genome and IN within the protective capsid lattice to ensure subse-
quent reverse transcription and productive infection in target cells. Conversely, dis-
ruption of these interactions by ALLINIs or mutations in IN leads to premature deg-
radation of both the viral RNA genome and IN, as well as the spatial separation of
reverse transcriptase from the viral genome during early steps of infection.
IMPORTANCE Recent evidence indicates that HIV-1 integrase (IN) plays a key role
during particle maturation by binding to the viral RNA genome. Inhibition of IN-RNA
interactions yields aberrant particles with the viral ribonucleoprotein complexes
(vRNPs) eccentrically localized outside the conical capsid lattice. Although these par-
ticles contain all of the components necessary for reverse transcription, they are
blocked at an early reverse transcription stage in target cells. To explain the basis of
this defect, we tracked the fates of multiple viral components in infected cells. Here,
we show that the viral RNA genome and IN in eccentric particles are prematurely
degraded, whereas reverse transcriptase remains active and stably associated within
the capsid lattice. We propose that IN-RNA interactions ensure the packaging of
both vRNPs and IN within the protective capsid cores to facilitate subsequent re-
verse transcription and productive infection in target cells.
KEYWORDS ALLINIs, capsid, HIV-1, integrase, maturation, protein-RNA interaction,
RNA packaging, TRIM5, reverse transcriptase
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The genesis of infectious HIV-1 particles is a multistep process orchestrated bythe HIV-1 polyproteins Gag and Gag-Pol. Recruitment of a single viral RNA
genome dimer by a small number of Gag molecules to the plasma membrane
nucleates the assembly of thousands of Gag and hundreds of Gag-Pol molecules
into an immature virion (1). Thereafter, cleavage of Gag and Gag-Pol polyproteins
by the virally encoded protease enzyme liberates these polyproteins to their
constituent domains, triggering virion maturation. In mature virions, the cleaved
nucleocapsid (NC) domain of Gag condenses with the viral RNA (vRNA) genome inside
the conical core, composed of the capsid (CA) protein (1). Importantly, RNA (viral or
cellular) has been shown to play a structural role in viral particles (2, 3). Although the
proposed models of virion maturation have been largely centered on proteolytic
cleavage events of Gag, recent studies have revealed an active role of integrase (IN) in
encapsidation of the viral RNA genome within the mature conical CA lattice (4).
Early mutagenesis screens of IN have demonstrated that certain mutations, collec-
tively referred to as class II IN mutations, are pleiotropic and adversely affect particle
assembly, maturation, and reverse transcription (5–16). Interestingly, deletion of IN and
certain class II IN mutations leads to profound morphological defects in virions. In these
particles, the viral ribonucleoprotein complexes (vRNPs), mainly composed of the viral
genomic RNA and NC, are eccentrically localized between the empty CA lattice and the
viral membrane (7, 9, 17). A remarkably similar morphological defect is observed in
particles generated in the presence of allosteric integrase inhibitors (ALLINIs) (also
known as LEDGINs, NCINIs, or INLAIs) (18–23). Proposed mechanisms that underlie this
morphogenesis defect include ALLINI-induced aberrant IN multimerization (9, 17, 24–
27) and inhibition of IN binding to the viral RNA genome (4).
While a large fraction of eccentric particles contain irregularly shaped nonconical CA
assemblies (9, 17, 24), they appear to retain all of the components necessary for reverse
transcription, i.e., a dimeric viral RNA genome primed with tRNA-Lys, functional reverse
transcriptase (RT) (23), and normal levels of NC-RNA complexes (4, 17). Nevertheless,
these particles are blocked at an early reverse transcription stage in target cells (9, 11,
13, 24), the basis of which remains unknown. An anticipated, but currently untested,
possibility is that in addition to the vRNPs, other components of the viral core (i.e., RT
and IN) are mislocalized in eccentric particles and encounter unexpected fates in target
cells.
From a different perspective, examination of how eccentric particles behave in
infected cells may broaden our understanding of early postentry events, including viral
uncoating, reverse transcription, and TRIM5 restriction. Optimal stability of the CA
lattice and its timely uncoating have previously been proposed to be important for
reverse transcription (28–35). Nevertheless, higher-order CA structures must still exist in
cells because the host restriction factor TRIM5 recognizes structural features that exist
only in viral cores but not in individual CA monomers (36–39). However, the presence
of a conical core is likely not necessary for TRIM5 restriction, as a CA-NC cleavage
mutant that does not form conical cores can efﬁciently saturate TRIM5 restriction (40),
and TRIM5 can form lattices around hexameric CA-NC assemblies in vitro (41). As such,
determining whether the aberrantly formed CA lattices in eccentric particles are stable
in target cells despite lack of reverse transcription and whether they can be recognized
by TRIM5 proteins will further our knowledge of not only the morphological defects in
eccentric particles, but also early viral postentry events.
In this study, we set out to determine why eccentric particles, generated in the
presence of ALLINIs or through mutations within IN are blocked at an early reverse
transcription stage in target cells. Furthermore, we wanted to examine whether the
nonconical CA lattice in the eccentric particles retains features that can be recognized
by a restricting TRIM5 protein. Here, we provide compelling evidence that upon
infection of target cells, eccentrically localized viral RNA genomes, as well as IN, are
prematurely degraded in a proteasome-independent manner, whereas RT remains
active and stably associated with the CA lattice. Importantly, neither the total number
of NC-RNA complexes nor the footprint of NC on viral RNAs is affected in particles
Madison et al. Journal of Virology
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generated in the presence of ALLINIs. Notably, the CA lattice in eccentric particles can
efﬁciently saturate and be degraded by a restricting TRIM5 protein, suggesting that CA
proteins are organized in a hexagonal lattice despite the morphological aberrations.
Overall, our ﬁndings suggest that spatial separation of RT from vRNPs and premature
degradation of the viral RNA genome in target cells underlie the reverse transcription
defect of eccentric particles in target cells. We propose that IN-RNA interactions
mediate correct localization of the viral RNA genome, RT, and IN within the CA lattice
to prevent their premature degradation in target cells.
RESULTS
Effects of BI-B2 treatment on the fates of core components in target cells. To
determine why eccentric viral particles, generated in the presence of ALLINIs, fail to
support reverse transcription in target cells, we monitored the fates of eccentric particle
components in infected cells. To this end, we took advantage of a previously developed
elaborate approach with which we biochemically tracked multiple core components in
infected cells (42). In brief, pgsA-745 or pgsA-745-derived cells stably expressing a
nonrestricting human TRIM5 (huTRIM5) protein were synchronously infected at 4°C
with mock- or BI-B2-treated particles. Note that we chose to primarily work with
pgsA-huTRIM5 cells, as they are equally permissive to HIV-1 replication as the un-
modiﬁed pgsA-745 cells (42) and served as a matched control for the studies involving
restricting TRIM5 proteins detailed below. Following infections, postnuclear material
was harvested either immediately after virus binding (T  0) or after 2 h of incubation
at 37°C (T  2 h) and was separated by size on linear sucrose gradients. The collected
fractions were analyzed by immunoblotting for the viral proteins IN and CA, as well as
quantitative-PCR (Q-PCR)-based assays for viral RNA, cDNA, and RT activity.
In line with previous studies (43), wild-type (WT) particles generated in the presence
of BI-B2 exhibited a nearly 10-fold infectivity defect (Fig. 1A), whereas the HIV-1A128T IN
mutant virus was markedly resistant to BI-B2 (Fig. 1A). As expected, BI-B2 treatment did
not affect the binding of virions to cells, as similar levels of CA (Fig. 1B), IN (Fig. 1B), and
vRNA (Fig. 1C) were present primarily in sucrose fractions 6 to 8 for both mock- and
BI-B2-treated particles, representing virions that are bound to plasma membrane
fragments of various sizes. In contrast, analysis of viral core components at 2 hours
postinfection revealed remarkably different fates for the components of mock- and
BI-B2-treated particles. As previously observed (42), for mock-treated particles, a large
fraction of CA was detected in the top two fractions (Fig. 1D), representing soluble CA
that either was not assembled into viral cores (44) or had uncoated. A smaller popu-
lation of CA was present in the denser fractions, representing the larger reverse
transcription complexes (Fig. 1D). Notably, comparable levels and distribution patterns
of CA were detected in sucrose fractions for BI-B2-treated particles (Fig. 1D). While IN
and vRNA comigrated with CA in the dense fractions for mock-treated particles (Fig. 1D
and E), BI-B2 treatment led to a nearly complete loss of IN and a signiﬁcant reduction
in vRNA in the dense fractions without a concurrent increase in the top fractions
containing soluble RNAs and proteins (Fig. 1D and E). These changes were accompa-
nied by a similar degree of reduction in reverse transcription products (Fig. 1F).
To ensure that degradation of IN and RNA was not due to overexpression of
huTRIM5 or an indirect effect of BI-B2 treatment, we conducted similar experiments in
unmodiﬁed pgsA cells using the BI-B2-resistant HIV-1A128T IN mutant virus (Fig. 1A) (43).
In line with the above-described ﬁndings, BI-B2 treatment of neither HIV-1WT nor
HIV-1A128T IN affected the levels and behavior of CA protein in sucrose gradients (Fig.
1G). In contrast, while BI-B2 treatment of WT particles signiﬁcantly reduced the levels
of IN (Fig. 1G) and vRNA (Fig. 1H) in dense fractions, BI-B2 treatment of HIV-1A128T IN had
no discernible effect on the levels or the migration patterns of IN and vRNA (Fig. 1G and
H). Notably, analysis of RT activity in sucrose fractions revealed that a large fraction of
RT comigrated with the larger CA-containing complexes and that BI-B2 treatment of WT
particles had no effect on the migration behavior of RT (Fig. 1I). These results collec-
Fates of Eccentric HIV-1 Particles in Target Cells Journal of Virology
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tively indicate that BI-B2 treatment of WT particles speciﬁcally leads to degradation of
IN and vRNA, as well as the spatial separation of RT from vRNPs in target cells.
Effects of BI-D treatment on fates of core components in target cells. To test
whether the above-described effects on viral core components were a general property
of ALLINIs, we conducted similar experiments with another ALLINI, BI-D, in pgsA-
huTRIM5 and unmodiﬁed pgsA cells. In line with the above-mentioned ﬁndings,
although BI-D treatment of WT particles had no effect on the migration pattern or the
levels of CA (Fig. 2A and D), it led to signiﬁcantly lower levels of IN (Fig. 2A and D), vRNA
(Fig. 2B and E), and cDNA (Fig. 2C and F) in dense sucrose fractions. Importantly, similar
amounts of RT comigrated with CA in the dense fractions for both mock- and BI-D-
treated particles (Fig. 2G), suggesting its retention within the larger CA complexes.
FIG 1 Fates of BI-B2-treated core components in target cells. (A) pgsA cells were infected in parallel with
mock- or BI-B2-treated VSV-G-pseudotyped GFP reporter HIV-1WT and HIV-1A128T IN. Virus titers were
determined 2 days postinfection (dpi) by FACS, and the titer of mock-treated WT virus was set to 100%. (B
to F) pgsA-huTRIM5 cells were infected with mock- or BI-B2-treated HIV-1WT/VSV-G. Infected cells were
processed at 0 h and 2 h as explained in Materials and Methods. (B and C) Western blot analysis of CA (p24)
and IN (B) and Q-RT-PCR analysis of viral RNA (C) in fractions collected from 0-h samples. (D to F) Western
blot analysis of CA and IN (D) and Q-RT-PCR analysis of viral RNA (E) and reverse transcription products (F)
in fractions collected from 2-h samples. (G to I) pgsA cells were infected with mock- or BI-B2-treated
HIV-1WT/VSV-G or HIV-1A128T IN/VSV-G. The infected cells were processed at 2 h as described above. (G and
H) Western blot analysis of CA (p24) and IN (G) and Q-PCR analysis of viral RNA (H). The data are
representative of the results of at least two independent experiments. (I) RT activity in collected fractions
was analyzed by a Q-PCR assay. Peak RT activity (i.e., in the 8th fraction) of mock-treated WT samples was
set to 100%. The data represent the averages of the results of two independent experiments; the error bars
show the ranges.
Madison et al. Journal of Virology
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Degradation and spatial separation of viral core components in BI-D-treated particles
were accompanied by an expected defect in infectivity (Fig. 2H). These results collec-
tively indicate that degradation of vRNA and IN and separation of RT from vRNPs are
common outcomes of ALLINI treatment.
Fates of HIVIN R269A/K273A core components in target cells. We next extended
these experiments to the R269A/K273A class II IN mutant, which speciﬁcally inhibits IN
binding to the viral RNA genome without affecting the catalytic activity of IN and leads
to formation of particles with the eccentric morphology (4). Although the nearby
K264A/K266A mutation similarly inhibits IN-RNA interactions and generates eccentric
particles, this mutation is pleiotropic and interferes with the catalytic activity of IN. As
such, we decided to focus on the R269A/K273A mutant in this study.
pgsA-huTRIM5 and pgsA cells were infected with HIV-1WT and HIV-1IN R269A/K273A
viruses, and cell lysates were analyzed following separation on sucrose gradients as
described above. As expected, the R269A/K273A IN mutation did not affect virion
binding to pgsA-huTRIM5 cells, as revealed by similar levels and distribution patterns
of CA (Fig. 3A), IN (Fig. 3A), vRNA (Fig. 3B), and RT (Fig. 3C) in the sucrose gradient. At
FIG 2 Fates of BI-D-treated core components in target cells. (A to F) pgsA-huTRIM5 (A to C) or unmodiﬁed
pgsA (D to F) cells were infected with mock- or BI-D-treated VSV-G-pseudotyped GFP reporter HIV-1WT. The
infected cells were processed at 2 h as explained in Materials and Methods. Western blot analysis of CA
(p24) and IN (A and D) and Q-RT-PCR analysis of viral RNA (B and E) and reverse transcription products (C
and F) in the collected fractions are shown. The data are representative of the results of at least two
independent experiments. (G) RT activity in fractions collected from pgsA-huTRIM5 cells infected with
BI-D-treated HIV-1WT/VSV-G were analyzed by a Q-PCR-based assay. Peak RT activity (i.e., in the 8th fraction)
of mock-treated samples was set to 100%. The data represent the averages of two independent experi-
ments; the error bars show the ranges. (H) Titers of mock- and BI-D-treated viruses on pgsA-huTRIM5 cells
were determined by FACS, and the titer of mock-treated WT virus was set to 100%. The data represent the
means and standard deviations (SD) of the results of three independent experiments.
Fates of Eccentric HIV-1 Particles in Target Cells Journal of Virology
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2 h postinfection, no detectable difference in the amount and distribution of CA was
observed for HIV-1WT and HIV-1IN R269A/K273A particles (Fig. 3D). In contrast, the IN
R269A/K273A mutation led to nearly complete loss of IN (Fig. 3D) and a large reduction
in vRNA (Fig. 3E) in dense sucrose fractions. Lack of a corresponding increase in top
FIG 3 Fates of HIV-1WT and HIV-1IN R269A/K273A core components in target cells. pgsA-huTRIM5 or unmodiﬁed pgsA cells
were infected in parallel with VSV-G-pseudotyped GFP reporter HIV-1WT or HIV-1IN R269A/K273A. The infected cells were
processed at 0 h and 2 h as explained in Materials and Methods. (A to C) Western blot analysis of CA (p24) and IN (A) and
Q-PCR analysis of viral RNA (B) and RT activity (C) in fractions collected at 0 h postinfection of pgsA-huTRIM5 cells. (D to F)
Western blot analysis of CA and IN (D) and Q-PCR analysis of viral RNA (E) and RT activity (F) in fractions collected from 2 h
postinfection of pgsA-huTRIM5 cells. (G to I) Western blot analysis of CA and IN (G) and Q-PCR analysis of viral RNA (H) and RT
activity (I) in fractions collected from 2 h postinfection of pgsA cells. (J and K) Q-PCR analysis of reverse transcription products
(cDNA) in fractions collected from pgsA-huTRIM5 (J) or pgsA (K) cells. The data are representative of the results of at least two
independent experiments. (L) pgsA-huTRIM5 cells were infected as described above, and virus titers were determined at 2 dpi
by FACS analysis. The data represent the means of two biological replicates. The error bars represent the ranges.
Madison et al. Journal of Virology




ber 5, 2017 by W






fractions containing soluble proteins and RNA likely indicates that viral RNA and IN from
eccentric particles are degraded. In line with the above-mentioned ﬁndings, similar
levels of RT comigrated with CA in the dense sucrose fractions for both WT and mutant
particles (Fig. 3F). Importantly, similar experiments conducted in pgsA cells also re-
vealed that IN and vRNA in HIV-1IN R269A/K273A particles were degraded (Fig. 3G and H),
whereas similar levels of CA and RT remained in dense sucrose fractions (Fig. 3G and I).
As expected, a reverse transcription (Fig. 3J and K) and subsequent infectivity (Fig. 3L)
defect accompanied the degradation of vRNA and separation of RT from vRNPs.
Collectively, these results indicate that degradation of vRNA, together with separation
of RT from vRNPs, contributes to the reverse transcription defect of eccentric particles
in target cells.
Importantly, the results shown in Fig. 1 to 3 were highly reproducible across multiple
independent experiments, as exempliﬁed by Q-PCR data showing degradation of vRNA
(Fig. 4A and B) and the reverse transcription defect (Fig. 4C and D) of eccentric particles.
Analysis of RNA degradation in MT4 cells infected with NL4-3-based full-length viruses
similarly revealed that a signiﬁcant fraction of eccentrically localized viral genomes
were degraded prematurely by 2 h following infection (Fig. 4E).
Multimeric state and localization of IN in eccentric particles. Given that IN in
eccentric particles is degraded in target cells (Fig. 1 to 3), we reasoned that its
localization in particles might be altered. To test this, we fractionated particle compo-
nents from ALLINI-treated WT virions and HIV-1IN R269A/K273A particles using sucrose
gradient fractionation following brief detergent treatment and analyzed the migration
patterns of CA, IN, and matrix protein (MA) by immunoblotting. It is important to note
that comparison of ALLINIs with the R269A/K273A IN mutation is particularly informa-
tive for delineating whether premature degradation of vRNA and IN is a consequence
of the aberrant IN multimerization or the inability of IN to bind vRNA. While ALLINIs
both induce aberrant IN multimerization (9, 17, 24–26) and block IN-RNA interactions
(4), the R269A/K273A substitutions impair the ability of IN to bind to vRNA in virions
without altering its multimeric state in vitro (4).
Upon separation, CA from WT virions migrated as two separate populations, with
the majority of CA in the top two fractions (1 and 2) and a smaller amount in fractions
7 to 9 (Fig. 5A). In line with previous ﬁndings that CA in eccentric particles migrates in
less dense sucrose fractions due to the lack of vRNPs (24, 26), analysis of cores isolated
from ALLINI-treated and HIV-1IN R269A/K273A particles revealed signiﬁcantly less CA in the
dense sucrose fractions (Fig. 5A) due to the loss of vRNPs (9, 17). For example, while the
CA signal in dense fractions peaked in the 8th and 9th fractions, the peak of CA signal
in eccentric particles was shifted toward the 7th and 8th fractions (Fig. 5B). As expected,
membrane-bound MA remained in the soluble fractions following lysis of WT and
eccentric particles (Fig. 5C).
Surprisingly, while WT IN comigrated with CA in dense fractions, R269A/K273A IN
was primarily present in the top, soluble-protein-containing fractions (Fig. 5D). Inter-
estingly, IN in BI-D- and BI-B2-treated particles largely migrated in the bottom fractions,
although a higher level of soluble IN in BI-D-treated particles was visible (Fig. 5D). The
migration behavior of ALLINI-treated IN is in line with a previous study that demon-
strated that IN and RT in particles generated in the presence of ALLINI, GS-B, comigrates
with the less dense CA cores (24). Possible explanations for the migration behavior of
IN in ALLINI-treated particles include its retention within the CA lattice or formation of
large IN aggregates outside or loosely associated with the CA lattice. Given that IN in
ALLINI-treated particles is degraded similarly to R269A/K273A IN (Fig. 1A and G and 2A
and D), we propose that the latter is a more likely possibility.
To better understand the differential migration patterns of IN described above, we
employed a complementary dynamic-light-scattering (DLS) approach to evaluate the
sizes of corresponding recombinant protein multimers in vitro (Fig. 5E). No large
particles were detected with untreated WT or R269A/K273A IN molecules, indicating
that the R269A/K273A substitutions did not induce higher-order multimerization of IN.
Fates of Eccentric HIV-1 Particles in Target Cells Journal of Virology
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In contrast, addition of BI-D or BI-B2 to WT IN led to the formation of large aggregates
with different sizes, 150 and 950 nm, respectively (Fig. 5E). These ﬁndings coupled
with previous observations that WT but not R269A/K273A IN binds viral RNA (4) help to
explain the differential migration patterns of these proteins: WT IN is part of a large
nucleoprotein complex inside the CA core, whereas the mutant IN migrates as a
FIG 4 Reproducibility across multiple experiments and in infected MT-4 cells. (A to D) pgsA-huTRIM5 or unmodiﬁed pgsA
cells infected with eccentric particles and processed as described in Materials and Methods were analyzed for degradation of
viral RNA (A and B) and lack of reverse transcription products (C and D). The Q-PCR signal (copies per microliter) in each fraction
was divided by the sum of the copy numbers in all the fractions to enable representation of independent experiments on the
same graph. (E) MT4 cells were infected with HIV-1NL4-3/VSV-G or HIV-1NL4-3 IN R269A/K273A/VSV-G in the presence of 25 M
nevirapine as described above. Q-PCR analysis of viral RNA at the indicated time points postinfection is presented. The data
represent means and SD; n  4 biological replicates.
Madison et al. Journal of Virology
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low-oligomeric-state protein that is selectively impaired for RNA binding and is likely
localized outside the CA lattice (Fig. 5B). While ALLINI-treated WT IN does not interact
with viral RNA (4), the large sizes of IN-ALLINI complexes observed in DLS experiments
(Fig. 5E) are fully consistent with IN from ALLINI-treated virions migrating in the dense
sucrose fractions.
NC-RNA interactions are not altered in eccentric particles. NC has been pro-
posed to regulate the maturation of the genomic RNA dimer in particles and to ensure
the speciﬁcity and efﬁciency of reverse transcription (45). Therefore, we reasoned that
modulation of the binding pattern of NC on vRNAs in eccentric particles might
contribute to the reverse transcription defect in target cells. To test this possibility, we
conducted NC UV cross-linking immunoprecipitation and sequencing (CLIP-seq) exper-
iments on HIV-1NL4-3 particles generated in the presence of BI-B2, as well as on a
FIG 5 Localization of viral core components in WT and eccentric particles. (A to D) WT, IN R269A/K273A
mutant, and BI-B2- and BI-D-treated particles were subjected to equilibrium density centrifugation
following lysis in 0.5% Triton X-100. Western blot analyses of CA (A), MA (C), and IN (D) in the collected
fractions are shown. (B) Quantitation of the CA Western blots. CA signal for each sample was normalized
relative to the CA signal in the second fraction. The data show the mean signals and ranges of 2
biological replicates. (E) DLS analysis of WT IN, R269A/K273A IN, WT IN plus BI-B2, and WT IN plus BI-D.
The data are representative of the results of two independent experiments.
Fates of Eccentric HIV-1 Particles in Target Cells Journal of Virology
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HIV-1NL4-3 A128T IN mutant that is markedly resistant to BI-B2 (Fig. 6A) (43). In line with
previous ﬁndings (4), similar amounts of NC-RNA complexes were immunoprecipitated
from mock- and BI-B2-treated HIV-1NL4-3 and HIV-1NL4-3 A128T IN particles (Fig. 6B). In
contrast, the binding of WT, but not A128T IN, to RNAs was dramatically reduced upon
FIG 6 NC-RNA interactions are not altered in eccentric particles. (A) Infectious titers of mock- and BI-B2-treated HIV-1WT
and HIV-1IN A128T particles were determined on NIH-TZM reporter cells and normalized relative to mock-treated
HIV-1NL4-3WT particles. The titers are means and SD; n 3 independent experiments. (B) Representative autoradiogram
of NC-RNA and IN-RNA adducts isolated from mock- and BI-B2-treated HIV-1NL4-3 WT and HIV-1NL4-3 IN A128T particles.
Corresponding Western blot analyses of NC and IN in virus Iysates are shown below the autoradiograms. (C) The
normalized number of reads that mapped to viral RNAs obtained from 2 independent IN-CLIP-seq experiments and
one NC-CLIP-seq experiment are shown relative to experiments conducted onWT particles. (D) NC CLIP-seq results showing
read densities (RPM) that mapped to the viral genome obtained from the indicated viruses and treatments. A colinear
diagram of HIV-1 genome features is shown above. Correlation analyses of data sets are represented on the right.
Madison et al. Journal of Virology
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BI-B2 treatment (Fig. 6B). Sequencing of NC- and IN-bound RNAs revealed that neither
the fraction of reads that mapped to the viral genome (Fig. 6C) nor the binding pattern
of NC on vRNAs (Fig. 6D) was affected in eccentric particles. In contrast, IN binding to
vRNA was signiﬁcantly reduced upon BI-B2 treatment of the WT (Fig. 6B and C), but not
the A128T IN mutant (Fig. 6B and C). These results show that despite the mislocalization
of NC-RNA complexes (4, 9, 17), the footprint of NC on vRNAs is maintained in the
eccentric particles.
Eccentric cores can efﬁciently saturate restricting TRIM5 molecules. As a signif-
icant fraction of eccentric particles contain aberrantly formed and nonconical CA
assemblies (17), we next wanted to determine whether they still retain features that can
be recognized by restricting TRIM5 molecules in cells. To this end, we performed
abrogation-of-restriction assays (36, 46), which rely on the saturation of restricting
TRIM5 proteins by increasing doses of TRIM5-sensitive capsids, resulting in infection by
viruses that would otherwise be restricted. pgsA-derived cells expressing rhesus ma-
caque TRIM5 (rhTRIM5) or owl monkey TRIMCyp (omkTRIMCyp) were infected
simultaneously with increasing amounts of VSV-G-pseudotyped WT or eccentric HIV-1
particles carrying a minimal viral genome (47) or full-length viral genomes (NL4-3) and
a ﬁxed amount of WT green ﬂuorescent protein (GFP) reporter virus. As negative
controls, we included the CA-LMNEIE (48) and CA-G89V (49) mutants, which confer
resistance to rhTRIM5 and omkTRIMCyp proteins, respectively.
HIV-1WT and HIV-1IN R269A/K273A particles containing minimal viral genomes abro-
gated rhTRIM5 (Fig. 7A) and omkTRIMCyp (Fig. 7B) restriction at similar efﬁciencies, as
indicated by the equivalent increases in the titer of a WT GFP reporter virus. In contrast,
HIV-1LMNEIE CA and HIV-1G89V CA viruses failed to abrogate restriction by rhTRIM5 (Fig.
7A) and omkTRIMCyp (Fig. 7B), respectively. Importantly, similar results were obtained
using full-length HIV-1NL4-3 and HIV-1NL4-3 IN R269A/K273A (Fig. 7C and D), suggesting that
the choice of viral genome in these experiments did not alter the biochemical effects
of the R269A/K273A IN mutation on particle formation. Finally, eccentric particles
generated in the presence of BI-B2 and BI-D abrogated rhTRIM5 (Fig. 7D) and
omkTRIMCyp (Fig. 7E) proteins, albeit at a modestly lower efﬁciency than mock-treated
particles. This can be attributed in part to ALLINI-mediated inhibition of integration in
target cells due to carryover of ALLINIs in the virus inoculum. Collectively, these results
indicate that the CA assemblies in eccentric particles still largely retain features that can
saturate TRIM5 molecules in infected cells.
CA assemblies in eccentric particles can be degraded by omkTRIMCyp. We next
wanted to extend these observations and asked whether CA assemblies in eccentric
particles can be targeted for degradation by the omkTRIMCyp protein. In the next set
of experiments, we primarily focused on HIV-1IN R269A/K273A particles, as the fates of viral
components in target cells were identical to those of ALLINI-treated particles (Fig. 1 to
3). pgsA-omkTRIMCyp and nonrestricting pgsA-huTRIM5 cells were infected with
HIV-1WT and HIV-1IN R269A/K273A in parallel, and postnuclear material was analyzed as
described above.
As revealed by the similar migration patterns and quantities of CA and IN, virion
binding to cells was equivalent under all conditions immediately after synchronization
of infections (T  0) (Fig. 8A). At 2 h postinfection with WT viruses (T  2 h), the
presence of omkTRIMCyp led to the expected disappearance of CA, IN (Fig. 8B),
vRNA (Fig. 8C), and cDNA (Fig. 8D) from the dense fractions without any concurrent
increase in the top fractions. In line with the saturation experiments, CA from
HIV-1IN R269A/K273A particles was similarly degraded by the omkTRIMCyp protein (Fig.
8B). Degradation of IN (Fig. 8B) and vRNA (Fig. 8C) following infection of omkTRIM-
Cyp cells with HIV-1IN R269A/K273A is likely due to an omkTRIMCyp-independent mech-
anism, as observed in huTRIM5 cells. As expected, cDNA synthesis was impaired in
huTRIM5 cells infected with HIV-1IN R269A/K273A (Fig. 8D). The presence of omkTRIMCyp
led to a further decrease in reverse transcription products (Fig. 8D), likely suggesting
the presence of a small fraction of particles with WT morphology in the virus popula-
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tion, as observed previously (17). Notably, while similar levels of RT activity were
present in dense sucrose fractions for WT and IN R269A/K273A mutant viruses under
nonrestrictive conditions, the presence of omkTRIMCyp led to a signiﬁcant decrease in
RT activity in these fractions (Fig. 8E). We noted a second peak of RT activity in the top
(1 to 4) sucrose fractions for WT particles (Fig. 1I, 3I, and 8E). As this population of RT
is insensitive to omkTRIMCyp restriction and does not comigrate with other viral
components, it likely represents soluble RT molecules that are not associated with
FIG 7 Eccentric particles efﬁciently saturate restricting TRIM5 proteins. Eccentric particles generated by
IN R269A/K273A mutation (NLGP and NL4-3 backbone) or BI-B2 or BI-D treatment, along with rhTRIM5-
resistant CA-LMNEIE mutants (NLGP backbone) and omkTRIMCyp-resistant CA-G89V mutants (NLGP
backbone), were tested for the ability to saturate rhTRIM5 (A, C, and E) and omkTRIMCyp (B, D, and F).
Cells were infected with the indicated VSV-G-pseudotyped abrogating viruses simultaneously with a
ﬁxed amount of WT GFP reporter virus. The titers of the abrogating viruses were determined on NIH-TZM
cells. The MOI of WT- and mock-treated viruses are indicated on the x axes. The viral inoculum for
eccentric particles was normalized to that of WT/mock-treated viruses based on RT activity. The
percentages of GFP-positive cells were determined 2 days postinfection by FACS and are shown on the
y axes. The data represent the averages of the results of two independent experiments. The error bars
show the ranges. Similar results were obtained from two other independent experiments done under
similar conditions.
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vRNPs. As expected, degradation of viral components was associated with a severe
infectivity defect downstream (Fig. 8F). Overall, these ﬁndings reinforce the conclusion
that RT remains associated with CA in eccentric particles and suggest that TRIM5 can
recognize and degrade the nonconical CA assemblies and the associated RT molecules.
Similar results were observed for ALLINI-treated particles; viral CA from eccentric
cores generated by BI-B2 and BI-D treatment was efﬁciently degraded by omkTRIMCyp
FIG 8 Eccentric cores generated through IN R269A/K273A mutation can be efﬁciently degraded by omkTRIMCyp.
pgsA-huTRIM5 and pgsA-omkTRIMCyp cells were infected with VSV-G-pseudotyped HIV-1WT or HIV-1IN R269A/K273A.
Infected cells were processed at 0 h and 2 h as described in Materials and Methods. (A and B) Western blot analysis of CA
(p24) and IN in fractions collected from 0-h (A) and 2-h (B) samples. (C to E) Q-PCR analysis of viral RNA (C), viral cDNA (D),
and RT activity (E) in fractions collected from 2-h samples. Peak RT activity (i.e., in the 7th fraction) of huTRIM5-WT samples
was set to 100%. (F) Virus titers on pgsA-huTRIM5 and pgsA-omkTRIMCyp cells infected in parallel were determined by
FACS 2 days postinfection. The data are representative of the results of two independent experiments.
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(Fig. 9A). Likewise, while ALLINI treatment reduced the amount of viral cDNA in dense
fractions, the presence of omkTRIMCyp led to a further decrease (Fig. 9B). Notably,
although ALLINI treatment did not affect the migration behavior or amount of RT,
omkTRIMCyp led to its complete loss from dense fractions (Fig. 9C). Overall, these
results show that the viral CA, together with associated RT, in eccentric particles can be
efﬁciently recognized and degraded by a restricting TRIM5 protein.
The viral RNA genome and IN from the eccentric particles are degraded in a
proteasome-independent manner. It has been proposed that the IN protein is
inherently unstable due to the presence of an N-terminal phenylalanine residue that
leads to its proteasomal degradation (50). Likewise, we reasoned that degradation of
NC in the cytosol may subsequently expose the vRNA for further degradation. To test
these possibilities, we conducted assays similar to those described above in pgsA-
huTRIM5 cells in the presence of the proteasome inhibitor MG132. As expected, the
migration patterns and amounts of CA in WT and eccentric particles were largely
unaffected upon MG132 treatment (Fig. 10A). However, MG132 treatment did not
restore IN (Fig. 10B), vRNA (Fig. 10C), or cDNA (Fig. 10D) in sucrose fractions and as a
result did not rescue the defect in infectivity (Fig. 10E) of HIV-1IN R269A/K273A.
Importantly, parallel experiments conducted in omkTRIMCyp cells indicated that
degradation of CA (Fig. 11A) and RT (Fig. 11B) can be rescued upon MG132 treatment
for both WT and eccentric particles. Although MG132 treatment restored IN (Fig. 10C),
vRNA (Fig. 11D), and cDNA (Fig. 11E) for HIV-1WT in omkTRIMCyp cells, it modestly, if at
all, restored these components for HIV-1IN R269A/K273A. As previously noted (42), MG132
treatment did not restore virion infectivity of HIV-1WT and HIV-1IN R269A/K273A particles
in omkTRIMCyp cells (Fig. 11F). In summary, these results indicated that the RNA
FIG 9 Eccentric cores generated in the presence of ALLINIs can be efﬁciently degraded by omkTRIMCyp. pgsA-huTRIM5
and pgsA-omkTRIMCyp cells were infected with mock-, BI-B2-, and BI-D-treated particles. The infected cells were processed
at 2 h as explained in Materials and Methods. Western blot analysis of CA (A) and Q-PCR analysis of viral cDNA (B) and RT
activity (C) in the collected fractions are shown. RT activity in the 7th fraction of mock-treated samples in huTRIM5 cells
was set to 100%. The data are representative of the results of two independent experiments.
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genome and IN from the eccentric particles are degraded in a proteasome-independent
manner under both nonrestricting and restricting conditions. In contrast, omkTRIMCyp-
mediated degradation of CA and RT from the eccentric virions is dependent on
proteasomes.
DISCUSSION
Our ﬁndings shed light on how inhibition of IN-RNA interactions by ALLINI treatment
or through mutagenesis of IN alters the fates of multiple HIV-1 core components in
virions and in target cells. We propose that IN binding to the viral RNA genome during
particle maturation ensures the incorporation of both vRNPs and IN in the conical CA
lattice. Inhibition of these interactions either directly by the R269A/K273A IN substitu-
tions or indirectly by ALLINI-induced aberrant IN multimerization leads to mislocaliza-
tion of vRNPs (9, 17) and possibly also IN in virions. These profound changes do not
affect the degree or the pattern of NC binding on vRNAs (Fig. 6), reﬂecting the
FIG 10 Inhibition of proteasomes does not rescue the degradation of eccentric core components in huTRIM5-
expressing cells. pgsA-huTRIM5 cells were infected in parallel by VSV-G-pseudotyped HIV-1WT or HIV-1IN R269A/K273A
in the absence or presence of 2 M MG132. The infected cells were processed at 2 h as explained in Materials and
Methods. (A to D) Western blot analysis of CA (A) and IN (B) and Q-RT-PCR analysis of viral RNA (C) and cDNA (D)
in fractions collected from 2-h samples. (E) Virus titers were determined in parallel on pgsA-huTRIM5 cells by FACS.
The data are representative of the results of two independent experiments.
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formation of vRNP condensation prior to and independently of the formation of the
core (51, 52). Most notably, while vRNA and IN in eccentric particles are subsequently
prematurely degraded, similar levels of RT remain associated with CA assemblies in WT
and eccentric particles upon infection of target cells. Altogether, we propose that
premature degradation of the viral RNA genome in target cells, coupled with separation
of RT from the eccentrically localized vRNPs, accounts for the reverse transcription block
of eccentric particles (Fig. 12).
Our ﬁndings suggest that exposed vRNA is degraded in target cells with a half-life
of 2 h. This correlates with a similarly high decay rate seen for mammalian mRNAs
(53). It has been proposed that the AU-rich nucleotide content may destabilize HIV-1
RNAs following their synthesis (54–56), much like several other cellular mRNAs encod-
ing cytokines and growth factors (57). It is unknown whether similar mechanisms can
operate on eccentrically located vRNAs or if other speciﬁc antiviral molecules target
FIG 11 Inhibition of proteasomes does not rescue the degradation of vRNA and IN but restores CA and RT
in omkTRIMCyp cells. pgsA-omkTRIMCyp cells were infected in parallel with VSV-G-pseudotyped HIV-1WT or
HIV-1IN R269A/K273A in the absence or presence of 2 M MG132. The infected cells were processed at 2 h as
explained in Materials and Methods. (A to E) Western blot analysis of CA (A) and IN (C) and Q-PCR analysis
of RT activity (B), viral RNA (D), and cDNA (E) in fractions collected from 2-h samples. RT activity in the 7th
fraction of WT samples in omkTRIMCyp cells was set to 100%. (F) Virus titers were determined in parallel
on pgsA-huTRIM5 and pgsA-omkTRIMCyp cells by FACS. The data are representative of the results of two
independent experiments.
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vRNAs for degradation. As a corollary, our ﬁndings imply that vRNAs in WT particles
may be inaccessible to host cell RNA metabolism or defense pathways in infected cells
due to their retention within the CA lattice. In line with this, it has recently been
proposed that HIV-1 reverse transcription products, but not vRNA, can be recognized
by the cytosolic DNA sensors cGAS and IFI16, likely as a result of uncoating of the CA
core following cDNA synthesis (58–61). Eccentric particles will provide a unique tool to
study whether incoming vRNAs contain sequence and structural features that can be
recognized by cytosolic RNA sensors and whether the CA lattice prevents access of
cytosolic sensors to vRNAs.
Density-based separation of core components generated in the presence of ALLINI,
GS-B, has previously indicated that IN and RT cofractionate with CA (24), implying that
IN and RT may still be retained inside the cores. Similarly, our results show that upon
separation, IN in ALLINI-treated particles migrated toward denser sucrose fractions (Fig.
5D), although differences between the migration patterns of BI-D- and BI-B2-treated IN
were noticeable (Fig. 5D). In contrast, the IN R269A/K273A mutant primarily migrated
in soluble fractions (Fig. 5D). The differences between these migration patterns can be
explained by the formation of IN multimers of various sizes induced upon ALLINI
treatment, as revealed by DLS experiments (Fig. 5E). Nevertheless, both the ALLINI-
treated IN and the IN R269A/K273A mutant are subsequently degraded in target cells.
While we cannot exclude the possibility that ALLINIs and the R269A/K273A substitu-
tions directly affect the stability of IN in target cells, our results imply that IN is either
mislocalized in or loosely associated with the CA lattice in eccentric virions. Although
our studies do not assign a direct role for IN in reverse transcription, it is noteworthy
that IN has been previously shown to associate with reverse transcription complexes
(62), which could be mediated by vRNA or direct IN-RT interactions (63). Collectively,
the present ﬁndings, together with previous reports, argue strongly for a critical role of
IN in the correct localization of vRNPs within the protective CA lattice for subsequent
productive reverse transcription in the target cells.
FIG 12 Schematic model of how inhibition of IN-RNA interactions alters the core morphology and fates
of core components in target cells.
Fates of Eccentric HIV-1 Particles in Target Cells Journal of Virology




ber 5, 2017 by W






Our results indicate that RT remains associated with viral CA in cells infected with
eccentric particles. A small fraction of RT molecules are likely still positioned on the
eccentrically localized vRNA genome. Nevertheless, as reverse transcription involves
multiple template-switching events on a highly structured template (64), multiple RT
molecules are required to complete reverse transcription (65). As such, we propose that
in addition to the rapid degradation of vRNPs, the spatial separation of RT from the
vRNA genome explains the reverse transcription defect of eccentric particles.
Cores isolated from eccentric virus particles were shown to sediment more slowly
due to the mislocalization of vRNPs outside the core (24, 26). In addition, a large fraction
of eccentric particles contain nonconical aberrantly formed cores (17), which may
contribute to their slow migration in sucrose gradients. While our ﬁndings with
detergent-treated particles are in line with these previous studies (Fig. 5A), we have
observed that the migration patterns of CA isolated from cells infected with WT and
eccentric particles (i.e., Fig. 1D and G, 2A and D, 3D and G, 9A, 10A, and 11A) are similar.
One explanation for this difference is that separation of cytosolic material in infected
cells is based on size but not density. As such, it is plausible that the size of the CA
lattice in eccentric particles is similar to that in WT particles despite the morphological
aberrations. Alternatively, the WT cores and the CA lattice in eccentric particles undergo
similar levels of uncoating in target cells and subsequently migrate in similar patterns.
Previous studies have demonstrated a general association between the stability of
CA cores and reverse transcription in infected cells (30–35). According to the currently
accepted models, viral cores exist in a metastable state in virions and “uncoat” in target
cells as a result of reverse transcription (66). Conversely, inhibition of reverse transcrip-
tion can prevent uncoating in infected cells (28, 29). Although reverse transcription is
impaired in eccentric particles, we did not observe a difference in the migration
behavior or quantity of CA in dense fractions between eccentric and WT particles.
Interestingly, some of the CA mutations that alter core stability have been reported to
cause similar morphological defects in particle formation with condensed vRNPs jux-
taposed near the viral membrane (30, 32, 33, 67–69). As such, we predict that degra-
dation of vRNAs, and perhaps other core components, may similarly account for the
reverse transcription defect of particles with altered core stabilities.
It is well established that TRIM5 restriction factors recognize features that exist not
in CA monomers, but in the assembled viral CA lattice (36–39). On the other hand,
formation of a conical core is not likely to be necessary for TRIM5 binding, as TRIM5 can
form a hexameric supralattice on CA-NC tubes in vitro (41), a CA-NC cleavage mutant
that cannot form conical capsids can still saturate TRIM5 restriction (40), and TRIM5-
mediated restriction has been shown to require a small fraction of CA subunits (70).
Importantly, virus-like particles containing only Gag and protease were found to
saturate TRIM5 restriction, albeit at a lower efﬁciency than WT particles (36). In line with
these previous studies, our ﬁndings indicate that despite the reported morphological
aberrations (17), CA proteins in eccentric particles must still be arranged in a hexagonal
lattice and retain features that can be recognized and degraded by a restricting TRIM5
protein (Fig. 7, 8, 9, and 11).
We have previously shown that TRIM5-mediated restriction involves proteasome-
mediated degradation of CA, IN, and viral nucleic acids (42). We now show that TRIM5
restriction also leads to the degradation of RT protected within CA assemblies in a
proteasome-dependent manner (Fig. 8, 9, and 11). As such, while our data do not
provide conclusive evidence as to whether TRIM5 restriction primarily requires degra-
dation or disassembly of viral cores, they suggest that all of the components of the viral
cores are degraded either actively or due to their inherent instability upon TRIM5
restriction.
Overall, our ﬁndings reveal that IN-RNA interactions during virion morphogenesis
ensure the correct localization of vRNA and IN inside the CA lattice to protect the viral
RNA genome and IN from premature degradation during subsequent infection of the
target cells. Conversely, the lack of IN binding to RNA leads to reduced stability of the
viral RNA genome in target cells, as well as the spatial separation between RT and
Madison et al. Journal of Virology
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vRNPs, which together result in the block of reverse transcription. Collectively, these
studies provide key insight into the mode of action of ALLINIs and elucidate the
mechanisms by which IN-RNA interactions regulate particle maturation and inﬂuence
subsequent early viral postentry processes.
MATERIALS AND METHODS
Cells, viruses, and infections. CHO K1-derived pgsA-745 cells (CRL-2242; ATCC) and all of their
derivatives expressing human TRIM5, rhesus macaque TRIM5, and owl monkey TRIMCyp were
described previously (42) and were maintained in Ham’s F12 medium (Life Technologies; 11765-054)
supplemented with 10% fetal bovine serum and 1 mM L-glutamine. HeLa-derived TZM-bl cells (NIH AIDS
Reagent Program) and HEK 293T cells (ATCC CRL-11268) were maintained in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% fetal bovine serum. MT-4 cells were maintained in RPMI medium
supplemented with 10% fetal bovine serum. Vesicular stomatitis virus G protein (VSV-G)-pseudotyped
viruses were produced by transfection of 293T cells with plasmids expressing HIV-1 NL4-3-derived
Gag-Pol (pNLGP), the V1B packageable vector genome (47, 71), or the CCGW vector genome carrying GFP
(36, 46) and VSV-G at a ratio of 5:5:1, respectively, using polyethyleneimine (PolySciences, Warrington, PA)
as described previously (72). In some experiments, cell culture medium on transfected 293T cells was
replenished with 10 M BIB-B2- and BI-D-containing medium to generate particles with eccentric
morphologies. MT-4 cells were infected with VSV-G-pseudotyped full-length NL4-3WT or NL4-3R269A/K273A
synchronously at 4°C in the presence of nevirapine. Following the removal of the virus inoculum, the cells
were washed extensively with 1 phosphate-buffered saline (PBS) and incubated at 37°C for 2, 5, or 24
h prior to the collection of total cellular RNA with TRIzol (Life Technologies).
Plasmids. Construction of the proviral plasmid V1B, which expresses a minigenome under the
cytomegalovirus (CMV) promoter and retains viral sequences bound by IN, such as TAR and RRE, has
been described previously (47, 71). The vector genome plasmid CCGW carrying a GFP reporter under the
control of the CMV promoter was described previously (36, 46). The HIV-1NL4-3-derived HIV-1 Gag-Pol
sequence was inserted into the pCR/V1 plasmid (pNLGP) and was described previously (47). A pCR/V1-
based NLGP expression plasmid carrying the IN R269A/K273A and CA G89V mutations was generated by
transferring sequences containing the mutations from an NL4-3-based plasmid using conventional
molecular biology tools. The NLGP-CA LMNEIE plasmid was previously described (48). HIV-1NL4-3-derived
proviral plasmids containing IN R269A/K273A and IN A128T mutations were described previously (4).
Analysis of virion core components in infected cells. Biochemical analysis of retroviral cores in
infected cells was performed as described previously (42). Brieﬂy, pgsA745 cells stably expressing
huTRIM5 or omkTRIMCyp were infected with VSV-G-pseudotyped single-cycle GFP reporter viruses or
their derivatives synchronously at 4°C. Following removal of the virus inoculum and extensive washes
with 1 PBS, the cells were incubated at 37°C for 2 h. For analysis of viral RNAs, 25 M nevirapine was
included throughout the infections. In other experiments, 2 M MG132 was included for inhibition of
proteasomal degradation. Cytosolic extracts were separated by ultracentrifugation on 10 to 50% sucrose
gradients using an SW50.1 rotor at 30,000 rpm for 1 h. Ten 500-l fractions from the top of the gradient
were collected, and CA, IN, vRNA, and DNA in each fraction were analyzed as previously described (42).
A SYBR green-based Q-PCR assay (73) was employed to determine reverse transcriptase activity in the
collected sucrose fractions. RT activity in the fractions was normalized relative to the highest level of
activity (in fraction 6 or 7) of the WT or mock-treated viruses.
Equilibrium density sedimentation of virion core components in vitro. 293T cells grown on
15-cm dishes were transfected, and cell-free virions collected from the cell culture supernatants were
pelleted through a 20% sucrose cushion. The pelleted virus particles were resuspended in 1 PBS and
treated with 0.5% Triton X-100 for 2 min at room temperature. Immediately thereafter, samples were
layered on top of 30 to 70% linear sucrose gradients in 1 STE buffer (100 mM NaCl, 10 mM Tris-Cl [pH
8.0], 1 mM EDTA) and centrifuged for 16 h at 4°C and 28,500 rpm, using an SW55Ti rotor. Then, 500-l
fractions were collected from the top and analyzed for CA, IN, and MA by immunoblotting.
Abrogation of TRIM5 restriction assays. The titers of viruses generated as described above were
determined on NIH-TZM-bl indicator cells by X-Gal (5-bromo-4-chloro-3-indolyl--D-galactopyranoside)
staining 2 days postinfection. As the abrogating eccentric particles are noninfectious, the virus inoculum
was normalized with respect to the relative reverse transcriptase activity in each virus stock by employing
a Q-PCR-based RT activity assay. For viruses generated in the presence of ALLINIs, virus stocks were ﬁrst
pelleted by a LentiX concentrator (Clontech) to prevent carryover of ALLINIs to target TRIM5-expressing
cells. pgsA-rhTRIM5 and pgsA-omkTRIMCyp cells were infected at increasing multiplicities of infection
(MOI) with abrogating WT and eccentric core-containing particles simultaneously with wild-type GFP
reporter virus (MOI 1, as determined on pgsA cells). Infected cells were ﬁxed with formaldehyde 2 days
postinfection and analyzed by ﬂuorescence-activated cell sorting (FACS).
CLIP-seq experiments. CLIP-seq experiments were conducted as described previously (74). Brieﬂy,
293T cells transfected with proviral plasmids were grown in the presence of 4-thiouridine and treated
with ALLINIs or were left untreated for 16 h prior to virus harvest. Cell culture supernatants containing
virions were collected and ﬁltered through a 0.22-m ﬁlter and pelleted on a 20% sucrose cushion. The
virus pellets were resuspended in PBS and UV cross-linked. Following lysis, IN-RNA and NC-RNA
complexes were immunoprecipitated using monoclonal anti-IN and polyclonal anti-NC antibodies.
Bound RNA was end labeled with [-32P]ATP and T4 polynucleotide kinase. The isolated protein-RNA
complexes were separated by SDS-PAGE, transferred to nitrocellulose membranes, and exposed to
autoradiography ﬁlms. Protein-RNA complexes that corresponded to IN-RNA and NC-RNA adducts were
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excised from the membranes, and RNA was puriﬁed by proteinase K digestion. The RNA was sequentially
ligated to 3= and 5= adapters, reverse transcribed, and PCR ampliﬁed, and the resulting DNA library was
subjected to sequencing by Illumina platforms. The remainder of the data analysis was followed as
detailed previously (74), using a FASTX toolkit (http://hannonlab.cshl.edu/fastx_toolkit) and Bowtie (75).
Brieﬂy, sequencing reads were ﬁrst trimmed off the 3= adapter, reads shorter than 15 nucleotides were
ﬁltered out, and the library was demultiplexed based on the 5= adapter sequences using the FASTX
toolkit. The sequences were then collapsed into unique reads, followed by trimming off the 5= adapter
using the FASTX toolkit. The resulting reads were mapped to the reference viral genome (pNL4-3)
containing a single repeat (R) region using the Bowtie algorithm by allowing two mismatches (v 2 m
1). The mapping data were further normalized, taking into account the differences in library size and,
subsequently, the number of mapped reads. To this end, the number of reads that mapped to each
nucleotide of the viral genome was multiplied by a scaling factor to represent reads per million mapped
reads (RPM). Correlation of data sets was done in a pairwise fashion as detailed previously (74).
Dynamic-light-scattering assays. Dimethyl sulfoxide (DMSO) or 5 M ALLINI was added to 200 nM
IN and incubated in a buffer containing 50 mM HEPES, pH 7.4, 2 mM dithiothreitol (DTT), 2 mM MgCl2,
and 1 M NaCl for 30 min at room temperature. The DLS signal was recorded using a Malvern Nano series
zetasizer instrument.
ACKNOWLEDGMENTS
This work was supported by NIH grants K22AI116258, R01AI062520, and P50GM103297
(to S.B.K.) and R01AI062520 and R01AI110310 (to M.K.).
We thank Michael Malim for the monoclonal antibodies against integrase, Paul D.
Bieniasz for the TRIM5-resistant CA plasmids, James Fuchs for ALLINIs, and Kasyap
Tenneti for technical assistance. We are also grateful to Ross Larue for critical reading
of the manuscript.
M.K.M., D.Q.L., J.E., A.N.O., D.T., and S.B.K. conceived the study, designed the exper-
iments, and analyzed the data. P.C.K. and M.K. designed and performed DLS experi-
ments. M.E. conducted the correlation analyses of the CLIP-seq data sets. S.B.K. super-
vised the work and wrote the paper with M.K.
REFERENCES
1. Sundquist WI, Krausslich HG. 2012. HIV-1 assembly, budding, and mat-
uration. Cold Spring Harb Perspect Med 2:a006924. https://doi.org/10
.1101/cshperspect.a006924.
2. Muriaux D, Mirro J, Harvin D, Rein A. 2001. RNA is a structural element
in retrovirus particles. Proc Natl Acad Sci U S A 98:5246–5251. https://
doi.org/10.1073/pnas.091000398.
3. Mattei S, Flemming A, Anders-Osswein M, Krausslich HG, Briggs JA,
Muller B. 2015. RNA and nucleocapsid are dispensable for mature HIV-1
capsid assembly. J Virol 89:9739–9747. https://doi.org/10.1128/JVI
.00750-15.
4. Kessl JJ, Kutluay SB, Townsend D, Rebensburg S, Slaughter A, Larue RC,
Shkriabai N, Bakouche N, Fuchs JR, Bieniasz PD, Kvaratskhelia M. 2016.
HIV-1 integrase binds the viral RNA genome and is essential during
virion morphogenesis. Cell 166:1257–1268 e12. https://doi.org/10.1016/
j.cell.2016.07.044.
5. Bukovsky A, Gottlinger H. 1996. Lack of integrase can markedly affect
human immunodeﬁciency virus type 1 particle production in the pres-
ence of an active viral protease. J Virol 70:6820–6825.
6. Engelman A. 1999. In vivo analysis of retroviral integrase structure and
function. Adv Virus Res 52:411–426. https://doi.org/10.1016/S0065
-3527(08)60309-7.
7. Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R. 1995.
Multiple effects of mutations in human immunodeﬁciency virus type 1
integrase on viral replication. J Virol 69:2729–2736.
8. Johnson BC, Metiﬁot M, Ferris A, Pommier Y, Hughes SH. 2013. A
homology model of HIV-1 integrase and analysis of mutations designed
to test the model. J Mol Biol 425:2133–2146. https://doi.org/10.1016/j
.jmb.2013.03.027.
9. Jurado KA, Wang H, Slaughter A, Feng L, Kessl JJ, Koh Y, Wang W,
Ballandras-Colas A, Patel PA, Fuchs JR, Kvaratskhelia M, Engelman A.
2013. Allosteric integrase inhibitor potency is determined through the
inhibition of HIV-1 particle maturation. Proc Natl Acad Sci U S A 110:
8690–8695. https://doi.org/10.1073/pnas.1300703110.
10. Mohammed KD, Topper MB, Muesing MA. 2011. Sequential deletion of
the integrase (Gag-Pol) carboxyl terminus reveals distinct phenotypic
classes of defective HIV-1. J Virol 85:4654–4666. https://doi.org/10.1128/
JVI.02374-10.
11. Lu R, Limon A, Devroe E, Silver PA, Cherepanov P, Engelman A. 2004.
Class II integrase mutants with changes in putative nuclear localization
signals are primarily blocked at a postnuclear entry step of human
immunodeﬁciency virus type 1 replication. J Virol 78:12735–12746.
https://doi.org/10.1128/JVI.78.23.12735-12746.2004.
12. Lu R, Ghory HZ, Engelman A. 2005. Genetic analyses of conserved
residues in the carboxyl-terminal domain of human immunodeﬁciency
virus type 1 integrase. J Virol 79:10356–10368. https://doi.org/10.1128/
JVI.79.16.10356-10368.2005.
13. Limon A, Devroe E, Lu R, Ghory HZ, Silver PA, Engelman A. 2002. Nuclear
localization of human immunodeﬁciency virus type 1 preintegration
complexes (PICs): V165A and R166A are pleiotropic integrase mutants
primarily defective for integration, not PIC nuclear import. J Virol 76:
10598–10607. https://doi.org/10.1128/JVI.76.21.10598-10607.2002.
14. Leavitt AD, Robles G, Alesandro N, Varmus HE. 1996. Human immuno-
deﬁciency virus type 1 integrase mutants retain in vitro integrase activity
yet fail to integrate viral DNA efﬁciently during infection. J Virol 70:
721–728.
15. Jenkins TM, Engelman A, Ghirlando R, Craigie R. 1996. A soluble active
mutant of HIV-1 integrase: involvement of both the core and carboxyl-
terminal domains in multimerization. J Biol Chem 271:7712–7718.
https://doi.org/10.1074/jbc.271.13.7712.
16. Shehu-Xhilaga M, Hill M, Marshall JA, Kappes J, Crowe SM, Mak J. 2002.
The conformation of the mature dimeric human immunodeﬁciency virus
type 1 RNA genome requires packaging of Pol protein. J Virol 76:
4331–4340. https://doi.org/10.1128/JVI.76.9.4331-4340.2002.
17. Fontana J, Jurado KA, Cheng N, Ly NL, Fuchs JR, Gorelick RJ, Engelman
AN, Steven AC. 2015. Distribution and redistribution of HIV-1 nucleo-
capsid protein in immature, mature, and integrase-inhibited virions: a
role for integrase in maturation. J Virol 89:9765–9780. https://doi.org/10
.1128/JVI.01522-15.
18. Christ F, Voet A, Marchand A, Nicolet S, Desimmie BA, Marchand D,
Bardiot D, Van der Veken NJ, Van Remoortel B, Strelkov SV, De Maeyer
M, Chaltin P, Debyser Z. 2010. Rational design of small-molecule inhib-
itors of the LEDGF/p75-integrase interaction and HIV replication. Nat
Chem Biol 6:442–448. https://doi.org/10.1038/nchembio.370.
19. Fader LD, Malenfant E, Parisien M, Carson R, Bilodeau F, Landry S, Pesant
Madison et al. Journal of Virology




ber 5, 2017 by W






M, Brochu C, Morin S, Chabot C, Halmos T, Bousquet Y, Bailey MD, Kawai
SH, Coulombe R, LaPlante S, Jakalian A, Bhardwaj PK, Wernic D, Schroe-
der P, Amad M, Edwards P, Garneau M, Duan J, Cordingley M, Bethell R,
Mason SW, Bos M, Bonneau P, Poupart MA, Faucher AM, Simoneau B,
Fenwick C, Yoakim C, Tsantrizos Y. 2014. Discovery of BI 224436, a
noncatalytic site integrase inhibitor (NCINI) of HIV-1. ACS Med Chem Lett
5:422–427. https://doi.org/10.1021/ml500002n.
20. Gupta K, Brady T, Dyer BM, Malani N, Hwang Y, Male F, Nolte RT, Wang
L, Velthuisen E, Jeffrey J, Van Duyne GD, Bushman FD. 2014. Allosteric
inhibition of human immunodeﬁciency virus integrase: late block during
viral replication and abnormal multimerization involving speciﬁc protein
domains. J Biol Chem 289:20477–20488. https://doi.org/10.1074/jbc
.M114.551119.
21. Kessl JJ, Jena N, Koh Y, Taskent-Sezgin H, Slaughter A, Feng L, de Silva
S, Wu L, Le Grice SF, Engelman A, Fuchs JR, Kvaratskhelia M. 2012.
Multimode, cooperative mechanism of action of allosteric HIV-1 inte-
grase inhibitors. J Biol Chem 287:16801–16811. https://doi.org/10.1074/
jbc.M112.354373.
22. Le Rouzic E, Bonnard D, Chasset S, Bruneau JM, Chevreuil F, Le Strat F,
Nguyen J, Beauvoir R, Amadori C, Brias J, Vomscheid S, Eiler S, Levy N,
Delelis O, Deprez E, Saib A, Zamborlini A, Emiliani S, Ruff M, Ledoussal B,
Moreau F, Benarous R. 2013. Dual inhibition of HIV-1 replication by
integrase-LEDGF allosteric inhibitors is predominant at the post-
integration stage. Retrovirology 10:144. https://doi.org/10.1186/1742
-4690-10-144.
23. van Bel N, van der Velden Y, Bonnard D, Le Rouzic E, Das AT, Benarous
R, Berkhout B. 2014. The allosteric HIV-1 integrase inhibitor BI-D affects
virion maturation but does not inﬂuence packaging of a functional RNA
genome. PLoS One 9:e103552. https://doi.org/10.1371/journal.pone
.0103552.
24. Balakrishnan M, Yant SR, Tsai L, O’Sullivan C, Bam RA, Tsai A, Niedziela-
Majka A, Stray KM, Sakowicz R, Cihlar T. 2013. Non-catalytic site HIV-1
integrase inhibitors disrupt core maturation and induce a reverse tran-
scription block in target cells. PLoS One 8:e74163. https://doi.org/10
.1371/journal.pone.0074163.
25. Desimmie BA, Schrijvers R, Demeulemeester J, Borrenberghs D, Weydert
C, Thys W, Vets S, Van Remoortel B, Hofkens J, De Rijck J, Hendrix J,
Bannert N, Gijsbers R, Christ F, Debyser Z. 2013. LEDGINs inhibit late
stage HIV-1 replication by modulating integrase multimerization in the
virions. Retrovirology 10:57. https://doi.org/10.1186/1742-4690-10-57.
26. Sharma A, Slaughter A, Jena N, Feng L, Kessl JJ, Fadel HJ, Malani N, Male
F, Wu L, Poeschla E, Bushman FD, Fuchs JR, Kvaratskhelia M. 2014. A new
class of multimerization selective inhibitors of HIV-1 integrase. PLoS
Pathog 10:e1004171. https://doi.org/10.1371/journal.ppat.1004171.
27. Gupta K, Turkki V, Sherrill-Mix S, Hwang Y, Eilers G, Taylor L, McDanal C,
Wang P, Temelkoff D, Nolte RT, Velthuisen E, Jeffrey J, Van Duyne GD,
Bushman FD. 2016. Structural basis for inhibitor-induced aggregation of
HIV integrase. PLoS Biol 14:e1002584. https://doi.org/10.1371/journal
.pbio.1002584.
28. Yang Y, Fricke T, Diaz-Griffero F. 2013. Inhibition of reverse transcriptase
activity increases stability of the HIV-1 core. J Virol 87:683–687. https://
doi.org/10.1128/JVI.01228-12.
29. Hulme AE, Perez O, Hope TJ. 2011. Complementary assays reveal a
relationship between HIV-1 uncoating and reverse transcription. Proc
Natl Acad Sci U S A 108:9975–9980. https://doi.org/10.1073/pnas
.1014522108.
30. Fitzon T, Leschonsky B, Bieler K, Paulus C, Schroder J, Wolf H, Wagner R.
2000. Proline residues in the HIV-1 NH2-terminal capsid domain: struc-
ture determinants for proper core assembly and subsequent steps of
early replication. Virology 268:294–307. https://doi.org/10.1006/viro
.1999.0178.
31. Forshey BM, von Schwedler U, Sundquist WI, Aiken C. 2002. Formation of
a human immunodeﬁciency virus type 1 core of optimal stability is
crucial for viral replication. J Virol 76:5667–5677. https://doi.org/10.1128/
JVI.76.11.5667-5677.2002.
32. Jiang J, Ablan SD, Derebail S, Hercik K, Soheilian F, Thomas JA, Tang S,
Hewlett I, Nagashima K, Gorelick RJ, Freed EO, Levin JG. 2011. The
interdomain linker region of HIV-1 capsid protein is a critical determi-
nant of proper core assembly and stability. Virology 421:253–265.
https://doi.org/10.1016/j.virol.2011.09.012.
33. Tang S, Murakami T, Agresta BE, Campbell S, Freed EO, Levin JG. 2001.
Human immunodeﬁciency virus type 1 N-terminal capsid mutants that
exhibit aberrant core morphology and are blocked in initiation of re-
verse transcription in infected cells. J Virol 75:9357–9366. https://doi.org/
10.1128/JVI.75.19.9357-9366.2001.
34. Yang R, Shi J, Byeon IJ, Ahn J, Sheehan JH, Meiler J, Gronenborn AM,
Aiken C. 2012. Second-site suppressors of HIV-1 capsid mutations: res-
toration of intracellular activities without correction of intrinsic capsid
stability defects. Retrovirology 9:30. https://doi.org/10.1186/1742-4690
-9-30.
35. Hulme AE, Kelley Z, Okocha EA, Hope TJ. 2015. Identiﬁcation of capsid
mutations that alter the rate of HIV-1 uncoating in infected cells. J Virol
89:643–651. https://doi.org/10.1128/JVI.03043-14.
36. Cowan S, Hatziioannou T, Cunningham T, Muesing MA, Gottlinger HG,
Bieniasz PD. 2002. Cellular inhibitors with Fv1-like activity restrict human
and simian immunodeﬁciency virus tropism. Proc Natl Acad Sci U S A
99:11914–11919. https://doi.org/10.1073/pnas.162299499.
37. Munk C, Brandt SM, Lucero G, Landau NR. 2002. A dominant block to
HIV-1 replication at reverse transcription in simian cells. Proc Natl Acad
Sci U S A 99:13843–13848. https://doi.org/10.1073/pnas.212400099.
38. Besnier C, Takeuchi Y, Towers G. 2002. Restriction of lentivirus in mon-
keys. Proc Natl Acad Sci U S A 99:11920–11925. https://doi.org/10.1073/
pnas.172384599.
39. Dodding MP, Bock M, Yap MW, Stoye JP. 2005. Capsid processing
requirements for abrogation of Fv1 and Ref1 restriction. J Virol 79:
10571–10577. https://doi.org/10.1128/JVI.79.16.10571-10577.2005.
40. Shi J, Aiken C. 2006. Saturation of TRIM5 alpha-mediated restriction of
HIV-1 infection depends on the stability of the incoming viral capsid.
Virology 350:493–500. https://doi.org/10.1016/j.virol.2006.03.013.
41. Ganser-Pornillos BK, Chandrasekaran V, Pornillos O, Sodroski JG,
Sundquist WI, Yeager M. 2011. Hexagonal assembly of a restricting
TRIM5alpha protein. Proc Natl Acad Sci U S A 108:534–539. https://doi
.org/10.1073/pnas.1013426108.
42. Kutluay SB, Perez-Caballero D, Bieniasz PD. 2013. Fates of retroviral core
components during unrestricted and TRIM5-restricted infection. PLoS
Pathog 9:e1003214. https://doi.org/10.1371/journal.ppat.1003214.
43. Feng L, Sharma A, Slaughter A, Jena N, Koh Y, Shkriabai N, Larue RC,
Patel PA, Mitsuya H, Kessl JJ, Engelman A, Fuchs JR, Kvaratskhelia M.
2013. The A128T resistance mutation reveals aberrant protein multi-
merization as the primary mechanism of action of allosteric HIV-1 inte-
grase inhibitors. J Biol Chem 288:15813–15820. https://doi.org/10.1074/
jbc.M112.443390.
44. Briggs JA, Simon MN, Gross I, Krausslich HG, Fuller SD, Vogt VM, Johnson
MC. 2004. The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol
11:672–675. https://doi.org/10.1038/nsmb785.
45. Levin JG, Mitra M, Mascarenhas A, Musier-Forsyth K. 2010. Role of HIV-1
nucleocapsid protein in HIV-1 reverse transcription. RNA Biol 7:754–774.
https://doi.org/10.4161/rna.7.6.14115.
46. Hatziioannou T, Cowan S, Goff SP, Bieniasz PD, Towers GJ. 2003. Restric-
tion of multiple divergent retroviruses by Lv1 and Ref1. EMBO J 22:
385–394. https://doi.org/10.1093/emboj/cdg042.
47. Zennou V, Perez-Caballero D, Gottlinger H, Bieniasz PD. 2004. APOBEC3G
incorporation into human immunodeﬁciency virus type 1 particles. J
Virol 78:12058–12061. https://doi.org/10.1128/JVI.78.21.12058-12061
.2004.
48. Soll SJ, Wilson SJ, Kutluay SB, Hatziioannou T, Bieniasz PD. 2013. Assisted
evolution enables HIV-1 to overcome a high TRIM5alpha-imposed ge-
netic barrier to rhesus macaque tropism. PLoS Pathog 9:e1003667.
https://doi.org/10.1371/journal.ppat.1003667.
49. Yoo S, Myszka DG, Yeh C, McMurray M, Hill CP, Sundquist WI. 1997.
Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J Mol
Biol 269:780–795. https://doi.org/10.1006/jmbi.1997.1051.
50. Mulder LC, Muesing MA. 2000. Degradation of HIV-1 integrase by the
N-end rule pathway. J Biol Chem 275:29749–29753. https://doi.org/10
.1074/jbc.M004670200.
51. de Marco A, Muller B, Glass B, Riches JD, Krausslich HG, Briggs JA. 2010.
Structural analysis of HIV-1 maturation using cryo-electron tomography.
PLoS Pathog 6:e1001215. https://doi.org/10.1371/journal.ppat.1001215.
52. Pettit SC, Moody MD, Wehbie RS, Kaplan AH, Nantermet PV, Klein CA,
Swanstrom R. 1994. The p2 domain of human immunodeﬁciency virus
type 1 Gag regulates sequential proteolytic processing and is required to
produce fully infectious virions. J Virol 68:8017–8027.
53. Yang E, van Nimwegen E, Zavolan M, Rajewsky N, Schroeder M, Mag-
nasco M, Darnell JE, Jr. 2003. Decay rates of human mRNAs: correlation
with functional characteristics and sequence attributes. Genome Res
13:1863–1872. https://doi.org/10.1101/gr.997703.
54. Maldarelli F, Martin MA, Strebel K. 1991. Identiﬁcation of posttranscrip-
Fates of Eccentric HIV-1 Particles in Target Cells Journal of Virology




ber 5, 2017 by W






tionally active inhibitory sequences in human immunodeﬁciency virus
type 1 RNA: novel level of gene regulation. J Virol 65:5732–5743.
55. Schwartz S, Campbell M, Nasioulas G, Harrison J, Felber BK, Pavlakis GN.
1992. Mutational inactivation of an inhibitory sequence in human im-
munodeﬁciency virus type 1 results in Rev-independent gag expression.
J Virol 66:7176–7182.
56. Schwartz S, Felber BK, Pavlakis GN. 1992. Distinct RNA sequences in the
gag region of human immunodeﬁciency virus type 1 decrease RNA
stability and inhibit expression in the absence of Rev protein. J Virol
66:150–159.
57. Wu X, Brewer G. 2012. The regulation of mRNA stability in mammalian
cells: 2.0. Gene 500:10–21. https://doi.org/10.1016/j.gene.2012.03.021.
58. Gao D, Wu J, Wu YT, Du F, Aroh C, Yan N, Sun L, Chen ZJ. 2013. Cyclic
GMP-AMP synthase is an innate immune sensor of HIV and other
retroviruses. Science 341:903–906. https://doi.org/10.1126/science
.1240933.
59. Lahaye X, Satoh T, Gentili M, Cerboni S, Conrad C, Hurbain I, El Marjou
A, Lacabaratz C, Lelievre JD, Manel N. 2013. The capsids of HIV-1 and
HIV-2 determine immune detection of the viral cDNA by the innate
sensor cGAS in dendritic cells. Immunity 39:1132–1142. https://doi.org/
10.1016/j.immuni.2013.11.002.
60. Rasaiyaah J, Tan CP, Fletcher AJ, Price AJ, Blondeau C, Hilditch L, Jacques
DA, Selwood DL, James LC, Noursadeghi M, Towers GJ. 2013. HIV-1
evades innate immune recognition through speciﬁc cofactor recruit-
ment. Nature 503:402–405. https://doi.org/10.1038/nature12769.
61. Monroe KM, Yang Z, Johnson JR, Geng X, Doitsh G, Krogan NJ, Greene
WC. 2014. IFI16 DNA sensor is required for death of lymphoid CD4 T cells
abortively infected with HIV. Science 343:428–432. https://doi.org/10
.1126/science.1243640.
62. Nermut MV, Fassati A. 2003. Structural analyses of puriﬁed human
immunodeﬁciency virus type 1 intracellular reverse transcription com-
plexes. J Virol 77:8196–8206. https://doi.org/10.1128/JVI.77.15.8196
-8206.2003.
63. Tekeste SS, Wilkinson TA, Weiner EM, Xu X, Miller JT, Le Grice SF, Clubb
RT, Chow SA. 2015. Interaction between reverse transcriptase and inte-
grase is required for reverse transcription during HIV-1 replication. J Virol
89:12058–12069. https://doi.org/10.1128/JVI.01471-15.
64. Saraﬁanos SG, Marchand B, Das K, Himmel DM, Parniak MA, Hughes SH,
Arnold E. 2009. Structure and function of HIV-1 reverse transcriptase:
molecular mechanisms of polymerization and inhibition. J Mol Biol
385:693–713. https://doi.org/10.1016/j.jmb.2008.10.071.
65. Julias JG, Ferris AL, Boyer PL, Hughes SH. 2001. Replication of pheno-
typically mixed human immunodeﬁciency virus type 1 virions containing
catalytically active and catalytically inactive reverse transcriptase. J Virol
75:6537–6546. https://doi.org/10.1128/JVI.75.14.6537-6546.2001.
66. Ambrose Z, Aiken C. 2014. HIV-1 uncoating: connection to nuclear entry
and regulation by host proteins. Virology 454-455:371–379. https://doi
.org/10.1016/j.virol.2014.02.004.
67. von Schwedler UK, Stemmler TL, Klishko VY, Li S, Albertine KH, Davis DR,
Sundquist WI. 1998. Proteolytic refolding of the HIV-1 capsid protein
amino-terminus facilitates viral core assembly. EMBO J 17:1555–1568.
https://doi.org/10.1093/emboj/17.6.1555.
68. Reicin AS, Ohagen A, Yin L, Hoglund S, Goff SP. 1996. The role of Gag in
human immunodeﬁciency virus type 1 virion morphogenesis and early
steps of the viral life cycle. J Virol 70:8645–8652.
69. von Schwedler UK, Stray KM, Garrus JE, Sundquist WI. 2003. Functional
surfaces of the human immunodeﬁciency virus type 1 capsid protein. J
Virol 77:5439–5450. https://doi.org/10.1128/JVI.77.9.5439-5450.2003.
70. Shi J, Friedman DB, Aiken C. 2013. Retrovirus restriction by TRIM5
proteins requires recognition of only a small fraction of viral capsid
subunits. J Virol 87:9271–9278. https://doi.org/10.1128/JVI.00713-13.
71. Jouvenet N, Simon SM, Bieniasz PD. 2009. Imaging the interaction of
HIV-1 genomes and Gag during assembly of individual viral particles.
Proc Natl Acad Sci U S A 106:19114–19119. https://doi.org/10.1073/pnas
.0907364106.
72. Durocher Y, Perret S, Kamen A. 2002. High-level and high-throughput
recombinant protein production by transient transfection of suspension-
growing human 293-EBNA1 cells. Nucleic Acids Res 30:E9. https://doi
.org/10.1093/nar/30.2.e9.
73. Pizzato M, Erlwein O, Bonsall D, Kaye S, Muir D, McClure MO. 2009. A
one-step SYBR Green I-based product-enhanced reverse transcriptase
assay for the quantitation of retroviruses in cell culture supernatants. J
Virol Methods 156:1–7. https://doi.org/10.1016/j.jviromet.2008.10.012.
74. Kutluay SB, Zang T, Blanco-Melo D, Powell C, Jannain D, Errando M,
Bieniasz PD. 2014. Global changes in the RNA binding speciﬁcity of HIV-1
gag regulate virion genesis. Cell 159:1096–1109. https://doi.org/10
.1016/j.cell.2014.09.057.
75. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and
memory-efﬁcient alignment of short DNA sequences to the human
genome. Genome Biol 10:R25. https://doi.org/10.1186/gb-2009-10-3-r25.
Madison et al. Journal of Virology




ber 5, 2017 by W
ashington University in St. Louis
http://jvi.asm.org/
D
ow
nloaded from
 
